Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome – Yahoo Finance

Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome  Yahoo Finance

Corcept Therapeutics Incorporated (CORT) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent …